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In contrast to epithelial cells, cardiomyocytes are connected by complex hybrid-type adher-
ing junctions, termed composite junctions (areae compositae). Composite junctions are
found to be composed of typical desmosomal as well as adherens junction proteins.There-
fore, in adult mammalian cardiomyocytes desmosomal proteins are not restricted to the
relatively small desmosomes but are indirectly involved in anchoring the myoﬁbrillar actin
ﬁlaments. Subsequent investigations revealed that the formation of composite junctions
is a rather late event during mammalian heart development and vertebrate heart evolution.
Nascent,moreroundshapedcardiomyocytesofearlydevelopmentalstagesareconnected
by desmosomes and separate adherens junctions quite similar to cells of epithelial origin.
During progression of development both types of adhering junctions seem to gradually
fuse at the two poles of the mature mammalian cardiomyocytes to establish the hybrid-
type composite junctions. Recently, we demonstrated that the specialized cardiomyocytes
of the cardiac conduction system exhibit high amounts of desmosomes, not fully estab-
lished composite junctions and adherens junctions. This underlines the fact that cells of
the cardiac conduction system are known to resemble cardiomyocytes in their nascent
state and do not undergo working myocardial differentiation. However, the astonishing
high amount of desmosomal protein containing adhering junctions connecting, e.g., Purk-
inje ﬁbers raises the possibility that pacemaker and conductive tissue may be affected by
desmosomal gene mutations in ARVC/D patients.
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EFFECTS OF MUTATIONS IN GENES ENCODING FOR
CARDIOMYOCYTE ADHERING JUNCTION COMPONENTS
Desmosomes and fasciae adhaerentes (sing.,fascia adhaerens),the
latter also termed adherens junctions are responsible for cell–
cell adhesion and are often subsumed under the collective term
adhering junctions. In various epithelia,like in the multistratiﬁed
skin epithelium,desmosomes,and adherens junctions are distinct
structures with only few shared components, such as, e.g., plako-
globin (Cowin et al., 1986). Desmosomes anchor the cytoskeletal
intermediate ﬁlaments and fasciae adhaerentes the cytoskeletal
actin microﬁlaments (Franke, 2009; Dubash and Green, 2011).
In the heart things are quite different and more complex. Adult
mammalian cardiomyocytes are for the most part connected by
adheringjunctionstermedareaecompositae (sing.,areacomposita)
orcompositejunctionstohighlighttheirhybridcharacter(Franke
et al., 2006, 2009; Pieperhoff et al., 2010a). Composite junctions
consistof both,typicaldesmosomalandtypicaladherensjunction
proteins(Frankeetal.,2006;Pieperhoffetal.,2010a).Incomposite
junctions desmosomal proteins are therefore indirectly involved
in supporting the myoﬁbrillar actin anchorage in N-cadherin
mediated cell–cell adhesion complexes (Goossens et al., 2007).
Today it is generally accepted that arrhythmogenic right ven-
tricular cardiomyopathy/dysplasia (ARVC/D) is in most of the
cases caused by mutations in desmosomal genes. Disease causing
mutationshavebeenfoundingenesencodingforthedesmosomal
plaque components plakophilin-2,desmoplakin,and plakoglobin
andthetransmembranedesmosomalcadherinsdesmoglein-2and
desmocollin-2 (see, e.g., Rampazzo et al., 2002; Norman et al.,
2005;Pilichouetal.,2006;Thieneetal.,2007;forfurtherreferences
pleaseseeRickeltandPieperhoff,2012).Althoughrare,mutations
insomenon-desmosomalproteinssuchas,desmin(seeFigure1),
transforming growth factor-β3 (TGFB3),transmembrane protein
43(TMEM43),ryanodinereceptor2(RYR2),laminsAandC,stri-
atinandtitinhavealsobeenassociatedwithARVC/Ddevelopment
(Rampazzo et al., 1995; Beffagna et al., 2005; Merner et al., 2008;
Klauke et al., 2010; Meurs et al., 2010; Quarta et al., 2011; Taylor
et al., 2011). ARVC/D is characterized by a progressive replace-
ment of contractile heart muscle tissue by ﬁbrotic and fat tissue
(“ﬁbrofatty replacement”) and severe arrhythmogenesis often fol-
lowed by sudden cardiac mortality. Fibrofatty replacement was
often but not exclusively found in the right ventricle (Bauce et al.,
2005; Lindstrom et al., 2005; Thiene et al., 2007). Homozygous
mutations in plakoglobin cause a syndromic disease form called
“Naxos disease”involving skin and hair abnormalities in addition
to the ARVC/D-type ﬁbrofatty replacement of the myocardium
(Protonotarios et al., 2001).
Functional alterations in ARVC/D most likely include alter-
ations in gap junctions and sodium channels as a result from
adhering junction defects (Kaplan et al., 2004; Sato et al., 2009,
2011). Furthermore, suppressed Wnt-signaling by nuclear plako-
globin may be involved in ﬁbrofatty replacement and ARVC/D
phenotype development (Garcia-Gras et al., 2006; MacRae et al.,
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2006; Hirschy et al., 2010; Lombardi et al., 2011). In earlier
investigations, cell contacts have been found to be an indepen-
dent factor for cardiomyocyte survival in vitro (Clark et al., 1998)
showing the general importance of these structures beside their
important role in cell–cell adhesion.
Overexpression of mutant desmosomal genes or introduction
of mutant desmosomal genes in mice (Pilichou et al., 2009) and
otheranimalmodelsystems(zebraﬁsh)willhelpfurthertounder-
standARVC/Ddiseasedevelopmentandtreatment(Macrae,2010;
Fabritz et al., 2011).
Recently, screening for novel candidates of ARVC/D caus-
ing genes have been for the ﬁrst time extended to typical fascia
adhaerens components, yet without striking results (Christensen
etal.,2011).However,manyothercandidategenes,localizedinthe
composite junctions within the intercalated disk may be included
in future screenings (e.g., Kargacin et al., 2006; Otten et al., 2010;
Seeger et al., 2010). Hopefully, this will improve molecular diag-
nostics, genetic testing, and genetic management of this disease
(Fressart et al., 2010).
POSSIBLE EFFECTS OF ARVC/D CAUSING GENE MUTATIONS
ON CELLS OF THE CARDIAC CONDUCTION SYSTEM
In the higher vertebrate heart muscle the rhythmic contraction of
single cardiomyocytes is secured by a hierarchical system which
includes the cardiac conduction system composed of pacemaker
and conductive tissue. Pacemaker and conductive tissue consists
of specialized cardiomyocytes which did not underwent working
myocardial differentiation (Christoffels et al., 2010). Cells of the
cardiacconductionsystemareinsulatedbyconnectivetissuefrom
the working myocardium in some areas of the heart (see Figure1;
see also,Anderson et al., 2009; Pieperhoff et al., 2010b). Electrical
impulses are generated by cells of the sinoatrial (SA) node and
travel to the atrioventricular (AV) node (Bakker et al., 2010). The
conduction velocity is greatly reduced in the AV node to allow
the atrium to contract before the ventricle (Mamlin and Fisch,
1965). The fast conduction system within the ventricle includes
thebundlesofHis(1893),therightandleftbundlebranches(RBB,
LBB) on either side of the ventricular septum and the meshwork
of Purkinje ﬁbers (Purkyne, 1845; Tawara, 1906; Shimada et al.,
2004; Miquerol et al., 2011).
Pathological alterations in the cardiac conduction system have
been described to cause sudden cardiac death before (e.g., Thiene
et al., 1983) but never been found nor described in cases of
ARVC/D. However, risk stratiﬁcation of ARVC/D patients using
ECGanalysesrevealedthat“prolongedPRinterval,prolongedQRS
in lead VI, and presence of bundle branch block were predictors
for adverse outcome”(Lemola et al., 2005).
Conductivecellshavebeenfoundtobeconnectedbyarelatively
high density of desmosomal protein containing desmosomes and
composite junctions (Pieperhoff et al., 2010b). Cell contacts of
conductivecellsresembleadheringjunctionsofnascentcardiomy-
ocytes (Pieperhoff and Franke, 2007; Pieperhoff et al., 2010b).
Desmocollin-2 and desmoplakin (see Figure 2) and all other
desmosomal as well as adherens junction components involved
in connecting cardiomyocytes can be found in adhering junc-
tions of Purkinje ﬁber cells (Pieperhoff et al., 2010b). This is why,
mutationsindesmosomal(andnon-desmosomal)genesresulting
FIGURE 1 | Shown is a cryostat cross-section through ovine Purkinje
ﬁbers. Double label immunoﬂuorescence microscopy was performed with
antibodies to desmin (red) and vimentin (green) in addition to nuclear DAPI
staining (blue). Note that the insulating connective tissue is strongly
positive for vimentin, whereas Purkinje ﬁbers are positive for desmin similar
to cardiomyocytes of the working myocardium. For experimental details
please see Pieperhoff et al. (2010b).
FIGURE 2 | Cryostat sections through ovine (A–C) and bovine (D)
Purkinje ﬁbers. (A–C) Double label immunoﬂuorescence microscopy with
antibodies to desmoplakin [red (A) and β-catenin green (B)].The overlay of
(A) and (B) is shown in (C) in addition to nuclear DAPI staining (blue). Note
the often dotted staining pattern but high abundance of the desmosomal
plaque component desmoplakin in conductive cells of the Purkinje ﬁbers.
(D) Desmocollin-2 antibody labeling (red) and DAPI staining (blue) merged
with the phase contrast image.The white dashed lines demarcate the
border between conductive tissue and insulating connective tissue. See
also Pieperhoff et al. (2010b).
inthedescribeddefectsinthemyocardiumcouldaffectcellsof the
cardiac conduction system similarly. This could then contribute
to severe arrhythmogenesis in ARVC/D patients and may explain
why the presence of left bundle branch blocks in ECG analyses
has been found to be a predictor for the adverse outcome of the
disease (Lemola et al., 2005). Possible disease mechanisms could
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include cell adhesion defects, alterations in gap junction localiza-
tionandfunction,resultingconductiondisturbanceandﬁbrofatty
replacement of cardiomyocytes of the conduction system as sim-
ilarly described in cardiomyocytes of the working myocardium
(Norgett et al., 2000; Norman et al., 2005; MacRae et al., 2006;
Herren et al., 2009; Sato et al.,2011).
SUMMARY AND CONCLUSION
Cardiomyocytes of the working myocardium and of the cardiac
conduction system share many similarities. The high abundance
of desmosomal protein containing adhering junctions connecting
cardiomyocytesoftheconductionsystemraisesthepossibilitythat
conductive and pacemaker tissue might be affected by desmoso-
malgenemutationsincasesofARVC/D.Evenminoralterationsin
cells of the cardiac conduction system could contribute to severe
arrhythmogenesis in ARVC/D patients.
ACKNOWLEDGMENTS
I thank the German Science Foundation (DFG) for funding of a
postdoctoral fellowship (Pi 869/1-1) and the British Heart Foun-
dation (BHF) for subsequent funding within the BHF Centres
of Research Excellence (BHF CoRE). Special thanks go to Prof.
WernerFranke(GermanCancerResearchCenter,Heidelberg,Ger-
many),Prof.JohnMullins,Dr.MartinDenvir,andDr.GillianGray
(QMRI,BHF Centre for Cardiovascular Science,Edinburgh,UK),
andtoProf.CalumMacRae(BrighamandWomen’sHospital,Har-
vardMedicalSchool,Boston,MA,USA)forsupportandscientiﬁc
discussions.
REFERENCES
Anderson, R. H., Yanni, J., Boyett, M.
R., Chandler, N. J., and Dobrzynski,
H. (2009). The anatomy of the car-
diac conduction system. Clin. Anat.
22, 99–113.
Bakker, M. L., Moorman, A. F., and
Christoffels, V. M. (2010). The atri-
oventricular node: origin, develop-
ment, and genetic program. Trends
Cardiovasc. Med. 20, 164–171.
Bauce, B., Basso, C., Rampazzo, A.,
Beffagna, G., Daliento, L., Frigo, G.,
Malacrida, S., Settimo, L., Danieli,
G., Thiene, G., and Nava, A. (2005).
Clinical proﬁle of four families
witharrhythmogenicrightventricu-
lar cardiomyopathy caused by dom-
inant desmoplakin mutations. Eur.
Heart J. 26, 1666–1675.
Beffagna, G., Occhi, G., Nava, A.,
Vitiello, L., Ditadi, A., Basso, C.,
Bauce, B., Carraro, G., Thiene, G.,
Towbin, J. A., Danieli, G. A., and
Rampazzo, A. (2005). Regulatory
mutations in transforming growth
factor-beta3 gene cause arrhythmo-
genic right ventricular cardiomy-
opathy type 1. Cardiovasc. Res. 65,
366–373.
Christensen,A. H., Benn, M., Tybjaerg-
Hansen, A., Haunso, S., and Svend-
sen, J. H. (2011). Screening of three
novel candidate genes in arrhyth-
mogenicrightventricularcardiomy-
opathy. Genet. Test. Mol. Biomarkers
15, 267–271.
Christoffels,V. M., Smits, G. J., Kispert,
A., and Moorman, A. F. (2010).
Development of the pacemaker tis-
sues of the heart. Circ. Res. 106,
240–254.
Clark, W. A., Decker, M. L., Behnke-
Barclay, M., Janes, D. M., and
Decker, R. S. (1998). Cell contact
as an independent factor modu-
lating cardiac myocyte hypertrophy
and survival in long-term primary
culture. J. Mol. Cell. Cardiol. 30,
139–155.
Cowin, P., Kapprell, H. P., Franke, W.
W., Tamkun, J., and Hynes, R. O.
(1986). Plakoglobin: a protein com-
mon to different kinds of intercel-
lular adhering junctions. Cell 46,
1063–1073.
Dubash, A. D., and Green, K. J. (2011).
Desmosomes. Curr. Biol. 21, R529–
R531.
Fabritz, L., Hoogendijk, M. G., Sci-
cluna, B. P., van Amersfoorth, S. C.,
Fortmueller, L., Wolf, S., Laakmann,
S., Kreienkamp, N., Piccini, I., Bre-
ithardt, G., Noppinger, P. R., Witt,
H., Ebnet, K., Wichter, T., Levkau,
B., Franke, W. W., Pieperhoff, S.,
de Bakker, J. M., Coronel, R., and
Kirchhof, P. (2011). Load-reducing
therapy prevents development of
arrhythmogenic right ventricular
cardiomyopathy in plakoglobin-
deﬁcient mice. J. Am. Coll. Cardiol.
57, 740–750.
Franke, W. W. (2009). Discovering the
molecular components of intercel-
lular junctions – a historical view.
Cold Spring Harb. Perspect. Biol. 1,
a003061.
Franke, W. W., Borrmann, C. M.,
Grund,C.,andPieperhoff,S.(2006).
The area composita of adhering
junctions connecting heart muscle
cells of vertebrates. I. Molecular
deﬁnition in intercalated disks of
cardiomyocytes by immunoelectron
microscopy of desmosomal pro-
teins. Eur. J. Cell Biol. 85, 69–82.
Franke, W. W., Rickelt, S., Barth, M.,
and Pieperhoff, S. (2009). The junc-
tions that don’t ﬁt the scheme: spe-
cial symmetrical cell-cell junctions
of their own kind. Cell Tissue Res.
338, 1–17.
Fressart, V., Duthoit, G., Donal, E.,
Probst, V., Deharo, J. C., Chevalier,
P.,Klug,D.,Dubourg,O.,Delacretaz,
E., Cosnay, P., Scanu, P., Extrami-
ana, F., Keller, D., Hidden-Lucet,
F., Simon, F., Bessirard, V., Roux-
Buisson,N.,Hebert,J.L.,Azarine,A.,
Casset-Senon, D., Rouzet, F., Lecar-
pentier,Y.,Fontaine,G.,Coirault,C.,
Frank,R.,Hainque,B.,andCharron,
P. (2010). Desmosomal gene analy-
sis in arrhythmogenic right ven-
tricular dysplasia/cardiomyopathy:
spectrum of mutations and clini-
cal impact in practice. Europace 12,
861–868.
Garcia-Gras, E., Lombardi, R., Gio-
condo,M. J.,Willerson,J. T.,Schnei-
der, M. D., Khoury, D. S., and Mar-
ian, A. J. (2006). Suppression of
canonical Wnt/beta-catenin signal-
ing by nuclear plakoglobin recapitu-
lates phenotype of arrhythmogenic
right ventricular cardiomyopathy. J.
Clin. Invest. 116, 2012–2021.
Goossens,S.,Janssens,B.,Bonne,S.,De
Rycke, R., Braet, F., van Hengel, J.,
and van Roy, F. (2007). A unique
and speciﬁc interaction between
alphaT-catenin and plakophilin-2
in the area composita, the mixed-
type junctional structure of cardiac
intercalated discs. J. Cell Sci. 120,
2126–2136.
Herren, T., Gerber, P. A., and Duru, F.
(2009). Arrhythmogenic right ven-
tricularcardiomyopathy/dysplasia:a
not so rare “disease of the desmo-
some” with multiple clinical pre-
sentations. Clin. Res. Cardiol. 98,
141–158.
Hirschy,A., Croquelois,A., Perriard, E.,
Schoenauer, R., Agarkova, I., Hoer-
strup, S. P., Taketo, M. M., Pedrazz-
ini, T., Perriard, J. C., and Ehler,
E. (2010). Stabilised beta-catenin in
postnatal ventricular myocardium
leads to dilated cardiomyopathy and
premature death. Basic Res. Cardiol.
105, 597–608.
His, J. W. (1893). The story of the atri-
oventricular bundle with remarks
concerning embryonic heart
activity with remarks concerning
embryonic heart movement in the
adult. Arb. Med. Klin. Leipzig 4,
289–318.
Kaplan, S. R., Gard, J. J., Protonotarios,
N., Tsatsopoulou, A., Spiliopoulou,
C.,Anastasakis,A.,Squarcioni,C. P.,
McKenna, W. J., Thiene, G., Basso,
C., Brousse, N., Fontaine, G., and
Safﬁtz, J. E. (2004). Remodeling of
myocyte gap junctions in arrhyth-
mogenicrightventricularcardiomy-
opathyduetoadeletioninplakoglo-
bin(Naxosdisease).HeartRhythm1,
3–11.
Kargacin, G. J., Hunt, D., Emmett, T.,
Rokolya,A.,McMartin,G.A.,Wirch,
E.,Walsh, M. P., Ikebe, M., and Kar-
gacin, M. E. (2006). Localization
of telokin at the intercalated discs
of cardiac myocytes. Arch. Biochem.
Biophys. 456, 151–160.
Klauke, B., Kossmann, S., Gaertner, A.,
Brand, K., Stork, I., Brodehl, A.,
Dieding, M., Walhorn, V., Ansel-
metti, D., Gerdes, D., Bohms, B.,
Schulz,U.,ZuKnyphausen,E.,Vorg-
erd, M., Gummert, J., and Milt-
ing, H. (2010). De novo desmin-
mutation N116S is associated with
arrhythmogenic right ventricular
cardiomyopathy. Hum. Mol. Genet.
19, 4595–4607.
Lemola, K., Brunckhorst, C., Helfen-
stein, U., Oechslin, E., Jenni, R.,
and Duru, F. (2005). Predictors
of adverse outcome in patients
with arrhythmogenic right ventric-
ulardysplasia/cardiomyopathy:long
term experience of a tertiary care
centre. Heart 91, 1167–1172.
Lindstrom,L.,Nylander,E.,Larsson,H.,
and Wranne,B. (2005). Left ventric-
ular involvement in arrhythmogenic
rightventricularcardiomyopathy–a
scintigraphicandechocardiographic
study. Clin. Physiol. Funct. Imaging
25, 171–177.
Lombardi, R., da Graca Cabreira-
Hansen, M., Bell, A., Fromm, R.
R., Willerson, J. T., and Mar-
ian, A. J. (2011). Nuclear plako-
globin is essential for differentia-
tion of cardiac progenitor cells to
www.frontiersin.org February 2012 | Volume 3 | Article 22 | 3Pieperhoff Cardiac conduction disturbance in ARVC/D
adipocytes in arrhythmogenic right
ventricular cardiomyopathy. Circ.
Res. 109, 1342–1353.
Macrae, C. A. (2010). Cardiac arrhyth-
mia: in vivo screening in the
zebraﬁsh to overcome complexity in
drug discovery. Expert Opin. Drug
Discov. 5, 619–632.
MacRae, C. A., Birchmeier, W., and
Thierfelder, L. (2006). Arrhythmo-
genic right ventricular cardiomy-
opathy: moving toward mechanism.
J. Clin. Invest. 116, 1825–1828.
Mamlin, J. J., and Fisch, C. (1965). Sus-
tained atrioventricular conduction
delay due to interpolated ventricu-
larprematuresystole.Am.J.Cardiol.
16, 765–766.
Merner,N. D.,Hodgkinson,K. A.,Hay-
wood, A. F., Connors, S., French,
V. M., Drenckhahn, J. D., Kup-
prion, C., Ramadanova, K., Thier-
felder, L., McKenna, W., Gallagher,
B., Morris-Larkin, L., Bassett, A.
S., Parfrey, P. S., and Young, T. L.
(2008). Arrhythmogenic right ven-
tricular cardiomyopathy type 5 is
a fully penetrant, lethal arrhythmic
disordercausedbyamissensemuta-
tion in the TMEM43 gene. Am. J.
Hum. Genet. 82, 809–821.
Meurs, K. M., Mauceli, E., Lahmers, S.,
Acland, G. M., White, S. N., and
Lindblad-Toh, K. (2010). Genome-
wide association identiﬁes a dele-
tion in the 3’ untranslated region
of striatin in a canine model of
arrhythmogenic right ventricular
cardiomyopathy. Hum. Genet. 128,
315–324.
Miquerol, L., Beyer, S., and Kelly, R. G.
(2011). Establishment of the mouse
ventricular conduction system. Car-
diovasc. Res. 91, 232–242.
Norgett, E. E., Hatsell, S. J., Carvajal-
Huerta, L., Cabezas, J. C., Common,
J., Purkis, P. E., Whittock, N., Leigh,
I. M., Stevens, H. P., and Kelsell,
D. P. (2000). Recessive mutation in
desmoplakin disrupts desmoplakin-
intermediate ﬁlament interactions
and causes dilated cardiomyopathy,
woolly hair and keratoderma. Hum.
Mol. Genet. 9, 2761–2766.
Norman, M., Simpson, M., Mogensen,
J., Shaw, A., Hughes, S., Syrris,
P., Sen-Chowdhry, S., Rowland, E.,
Crosby, A., and McKenna, W. J.
(2005). Novel mutation in desmo-
plakin causes arrhythmogenic left
ventricular cardiomyopathy. Circu-
lation 112, 636–642.
Otten, J., van der Ven, P. F., Vakeel, P.,
Eulitz, S., Kirfel, G., Brandau, O.,
Boesl, M., Schrickel, J. W., Linhart,
M., Hayess, K., Naya, F. J., Milt-
ing, H., Meyer, R., and Furst, D.
O. (2010). Complete loss of murine
Xin results in a mild cardiac phe-
notype with altered distribution of
intercalated discs. Cardiovasc. Res.
85, 739–750.
Pieperhoff,S.,Barth,M.,Rickelt,S.,and
Franke, W. W. (2010a). “Desmoso-
mal molecules in and out of adher-
ing junctions: normal and diseased
statesofepidermal,cardiacandmes-
enchymally derived cells,” Desmo-
somes and Desmosomal Cadherin
FunctioninSkinandHeartDiseases–
Advancements in Basic and Clinical
Research,” eds M. G. Mahoney, E. J.
Müller, and P. J. Koch (New York:
Hindawi), 11.
Pieperhoff, S., Borrmann, C. M.,
Grund, C., Barth, M., Rizzo, S.,
and Franke, W. W. (2010b). The
area composita of adhering junc-
tions connecting heart muscle cells
of vertebrates. VII. The different
types of lateral junctions between
the special cardiomyocytes of the
conduction system of ovine and
bovine hearts. Eur. J. Cell Biol. 89,
365–378.
Pieperhoff,S.,andFranke,W.W.(2007).
The area composita of adhering
junctions connecting heart mus-
cle cells of vertebrates. IV. Coales-
cence and amalgamation of desmo-
somal and adhaerens junction com-
ponents – late processes in mam-
malian heart development. Eur. J.
Cell Biol. 86, 377–391.
Pilichou, K., Nava, A., Basso, C.,
Beffagna, G., Bauce, B., Lorenzon,
A., Frigo, G.,Vettori,A.,Valente, M.,
Towbin,J.,Thiene,G.,Danieli,G.A.,
andRampazzo,A.(2006).Mutations
in desmoglein-2 gene are associated
witharrhythmogenicrightventricu-
larcardiomyopathy.Circulation 113,
1171–1179.
Pilichou, K., Remme, C. A., Basso, C.,
Campian, M. E., Rizzo, S., Bar-
nett, P., Scicluna, B. P., Bauce, B.,
van den Hoff, M. J., de Bakker, J.
M., Tan, H. L., Valente, M., Nava,
A., Wilde, A. A., Moorman, A.
F., Thiene, G., and Bezzina, C. R.
(2009). Myocyte necrosis underlies
progressive myocardial dystrophy in
mousedsg2-relatedarrhythmogenic
right ventricular cardiomyopathy. J.
Exp. Med. 206, 1787–1802.
Protonotarios,N.,Tsatsopoulou,A.,and
Fontaine, G. (2001). Naxos disease:
keratoderma, scalp modiﬁcations,
and cardiomyopathy. J. Am. Acad.
Dermatol. 44, 309–311.
Purkyne, J. E. (1845). Mikroskopisch-
neurologische Beobachtungen.
Arch. Anat. Physiol. Wiss. Med. 12,
281–295.
Quarta, G., Syrris, P., Ashworth, M.,
Jenkins, S., Zuborne Alapi, K., Mor-
gan, J., Muir, A., Pantazis, A.,
McKenna, W. J., and Elliott, P. M.
(2011). Mutations in the Lamin
A/C gene mimic arrhythmogenic
right ventricular cardiomyopathy.
Eur. Heart J. doi: 10.1093/eur-
heartj/ehr1451. [Epub ahead of
print].
Rampazzo, A., Nava, A., Erne, P., Eber-
hard, M., Vian, E., Slomp, P., Tiso,
N., Thiene, G., and Danieli, G. A.
(1995). A new locus for arrhyth-
mogenicrightventricularcardiomy-
opathy (ARVD2) maps to chromo-
some1q42-q43.Hum.Mol.Genet.4,
2151–2154.
Rampazzo, A., Nava, A., Malacrida, S.,
Beffagna, G., Bauce, B., Rossi, V.,
Zimbello, R., Simionati, B., Basso,
C., Thiene, G., Towbin, J. A., and
Danieli, G. A. (2002). Mutation in
human desmoplakin domain bind-
ing to plakoglobin causes a domi-
nant form of arrhythmogenic right
ventricular cardiomyopathy. Am. J.
Hum. Genet. 71, 1200–1206.
Rickelt, S. and Pieperhoff, S. (2012).
Mutations with pathogenic poten-
tial in proteins located in or at
the composite junctions of the
intercalated disk connecting mam-
malian cardiomyocytes: a reference
thesaurus for arrhythmogenic car-
diomyopathies as well as Naxos and
Carvajal diseases. Cell Tiss. Res. doi:
10.1007/s00441-012-1365-0
Sato, P. Y., Coombs, W., Lin, X.,
Nekrasova, O., Green, K. J., Isom,
L. L., Taffet, S. M., and Delmar,
M. (2011). Interactions between
ankyrin-g, plakophilin-2, and con-
nexin43 at the cardiac intercalated
disc. Circ. Res. 109, 193–201.
Sato, P. Y., Musa, H., Coombs, W.,
Guerrero-Serna, G., Patino, G. A.,
Taffet, S. M., Isom, L. L., and Del-
mar,M. (2009). Loss of plakophilin-
2 expression leads to decreased
sodium current and slower con-
duction velocity in cultured car-
diac myocytes. Circ. Res. 105,
523–526.
Seeger, T. S., Frank, D., Rohr, C., Will,
R., Just, S., Grund, C., Lyon, R.,
Ludde,M.,Koegl,M.,Sheikh,F.,Rot-
tbauer, W., Franke, W. W., Katus,
H. A., Olson, E. N., and Frey, N.
(2010). Myozap, a novel interca-
lated disc protein, activates serum
responsefactor-dependentsignaling
and is required to maintain cardiac
function in vivo. Circ. Res. 106,
880–890.
Shimada, T., Kawazato, H., Yasuda, A.,
Ono, N., and Sueda, K. (2004).
Cytoarchitecture and intercalated
disks of the working myocardium
and the conduction system in the
mammalian heart. Anat. Rec. A
Discov. Mol. Cell. Evol. Biol. 280,
940–951.
Tawara, S. (1906). Das Reizleitungssys-
tem des Säugetierherzens. Eine
anatomisch-histologische Studie über
das Atrioventrikularbündel und die
Purkinjeschen Fäden. Jena: Verlag
von Gustav Fisher.
Taylor,M.,Graw,S.,Sinagra,G.,Barnes,
C., Slavov, D., Brun, F., Pinamonti,
B., Salcedo, E. E., Sauer,W., Pyxaras,
S., Anderson, B., Simon, B., Bogo-
molovas, J., Labeit, S., Granzier, H.,
and Mestroni, L. (2011). Genetic
variation in titin in arrhythmogenic
right ventricular cardiomyopathy-
overlap syndromes. Circulation 124,
876–885.
Thiene, G., Corrado, D., and Basso, C.
(2007). Arrhythmogenic right ven-
tricular cardiomyopathy/dysplasia.
Orphanet. J. Rare Dis. 2, 45.
Thiene, G., Pennelli, N., and Rossi, L.
(1983). Cardiac conduction system
abnormalities as a possible cause
of sudden death in young athletes.
Hum. Pathol. 14, 707–709.
Conﬂict of Interest Statement: The
author declares that the research was
conducted in the absence of any com-
mercial or ﬁnancial relationships that
could be construed as a potential con-
ﬂict of interest.
Received: 05 January 2012; accepted: 30
January 2012; published online: 17 Feb-
ruary 2012.
Citation:PieperhoffS(2012)Genemuta-
tions resulting in the development of
ARVC/D could affect cells of the cardiac
conduction system. Front. Physio. 3:22.
doi: 10.3389/fphys.2012.00022
This article was submitted to Frontiers in
Cardiac Electrophysiology, a specialty of
Frontiers in Physiology.
Copyright © 2012 Pieperhoff. This is an
open-access article distributed under the
terms of the Creative Commons Attribu-
tionNonCommercialLicense,whichper-
mits non-commercial use, distribution,
and reproduction in other forums, pro-
vided the original authors and source are
credited.
Frontiers in Physiology | Cardiac Electrophysiology February 2012 | Volume 3 | Article 22 | 4